ÂÜÀòÂÒÂ×

The Development Team at Carbon Biosciences is responsible for advancing the company's proprietary gene therapy platform. This includes designing and optimizing novel parvovirus-based vectors, conducting preclinical studies to assess efficacy and safety, and developing analytical methods to ensure product quality. The team works collaboratively to push the boundaries of gene therapy, targeting specific diseases with high unmet needs.